Sangers (northern Ireland) Limited

POWER SEARCH PRICING

SOLUTIONS

sangers (northern ireland) limited Company Information

Company Number

NI018941

Next Accounts

Dec 2025

Directors

Peter Surgenor

Wendy Hall

View All

Shareholders

aah pharmaceuticals limited

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

Registered Address

2 marshalls road, belfast, bt5 6sr, BT5 6SR

Website

http://www.aah.co.uk

sangers (northern ireland) limited Estimated Valuation

£32.5m

Pomanda estimates the enterprise value of SANGERS (NORTHERN IRELAND) LIMITED at £32.5m based on a Turnover of £48.5m and 0.67x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Sangers (northern Ireland) Limited is a live company located in bt5 6sr, BT5 6SR with a Companies House number of NI018941. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 1985, it's largest shareholder is aah pharmaceuticals limited with a 100% stake. Sangers (northern Ireland) Limited is a mature, large sized company, Pomanda has estimated its turnover at £48.5m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Sangers (Northern Ireland) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

7 Strong

3 Regular

1 Weak

Size

annual sales of £48.5m, make it larger than the average company (£24.9m)

Growth

3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (5.6%)

EXPORT

Sangers (Northern Ireland) Limited's latest turnover from March 2024 is £48.5 million and the company has net assets of £13.2 million. According to their latest financial statements, we estimate that Sangers (Northern Ireland) Limited has 74 employees and maintains cash reserves of £4.4 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	48,505,692	48,945,226	47,443,123	38,338,194	41,658,505	39,755,005	70,432,948	245,462,215	197,296,342	220,885,331	225,611,650	223,284,365	215,393,280	213,988,221	199,848,741
Other Income Or Grants
Cost Of Sales	42,715,388	43,413,416	41,985,364	33,357,164	35,834,345	34,604,931	63,012,885	225,103,481	182,024,256	205,961,497	211,153,944	209,698,466	202,368,820	201,543,160	188,147,951
Gross Profit	5,790,304	5,531,810	5,457,759	4,981,030	5,824,160	5,150,074	7,420,063	20,358,734	15,272,086	14,923,834	14,457,706	13,585,899	13,024,460	12,445,061	11,700,790
Admin Expenses	4,059,736	3,830,497	3,955,571	2,512,007	2,102,934	1,960,755	6,031,757	20,094,646	10,895,900	10,135,812	9,633,145	7,289,372	8,153,658	7,771,174	7,338,884
Operating Profit	1,730,568	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,388,306	264,088	4,376,186	4,788,022	4,824,561	6,296,527	4,870,802	4,673,887	4,361,906
Interest Payable					9,907	201,814	281,194	683,240	822,000	1,010,027	1,693,532	1,958,148	1,842,123	1,730,706	2,782,847
Interest Receivable	256,338	241,430	115	11,143	68,180	36,405		9,275	643,387	696,971	699,774	741,611	2,708,532	1,759,008	673,099
Pre-Tax Profit	1,986,906	1,942,743	1,502,303	2,480,166	3,779,499	3,023,910	1,107,112	-2,550,069	4,290,573	77,642,600	6,926,888	8,579,990	5,737,211	4,702,189	3,510,733
Tax		753,512	-268,603	-470,286	-615,183	-506,175	-689,714	593,134	-901,766	-803,049	-713,239	-1,169,216	-1,253,118	-1,229,306	-498,978
Profit After Tax	1,986,906	2,696,255	1,233,700	2,009,880	3,164,316	2,517,735	417,398	-1,956,935	3,388,807	76,839,551	6,213,649	7,410,774	4,484,093	3,472,883	3,011,755
Dividends Paid	3,000,000							10,050,000	1,000,000	76,166,485	3,750,000	6,000,000	3,000,000	2,000,000
Retained Profit	-1,013,094	2,696,255	1,233,700	2,009,880	3,164,316	2,517,735	417,398	-12,006,935	2,388,807	673,066	2,463,649	1,410,774	1,484,093	1,472,883	3,011,755
Employee Costs							2,913,857	10,829,340	7,144,330	6,581,898	6,703,521	4,964,355	6,580,827	6,209,762	5,853,166
Number Of Employees	74	76	76	62	71	67	84	206	216	223	227	235	230	277	269
EBITDA*	1,730,568	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,849,135	2,427,267	5,549,390	5,921,428	5,851,139	7,039,221	5,693,877	5,613,149	5,237,567

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets								9,739,110	12,969,297	12,572,664	12,750,787	10,757,145	8,063,106	8,031,136	8,317,830
Intangible Assets								224,891	32,094	39,500	46,906	54,312	61,720	69,126	76,532
Investments & Other	776,902	776,902	776,905	777,902	777,902	852,704	777,903	2,252,242	1,267,236	777,907	978,406	978,406	978,406	978,406	978,406
Debtors (Due After 1 year)
Total Fixed Assets	776,902	776,902	776,905	777,902	777,902	852,704	777,903	12,216,243	14,268,627	13,390,071	13,776,099	11,789,863	9,103,232	9,078,668	9,372,768
Stock & work in progress	6,163,120	6,726,832	5,628,463	6,509,623	3,995,117	4,702,687	3,596,009	7,231,610	11,295,743	11,543,361	11,998,748	11,982,177	13,523,888	11,480,231	10,398,396
Trade Debtors	4,693,327	4,760,502	5,058,451	3,268,187	5,012,403	4,330,277	4,349,039	16,801,514	29,823,362	34,469,578	38,252,843	37,529,851	37,467,050	37,643,375	37,285,798
Group Debtors	688,847	4,131,304	4,299,862	1,266,995	1,216,148	2,054,720	3,730,386	1,951,740	3,136,894	4,031,058	10,186,940	10,336,174	10,564,157	8,110,459	7,106,023
Misc Debtors	5,397,230	4,598,100	3,492,634	3,830,833	3,229,950	2,069,815	2,050,730	2,686,515	1,744,243	2,429,661	1,941,060	3,721,781	4,226,075	4,781,081	7,022,397
Cash	4,418,284	2,967,347	1,308,151	6,203,307	4,667,934	7,528,468	7,717,498	9,748,122	15,604,537	11,599,844	9,908,629	9,076,043	9,918,678	10,447,973	5,882,069
misc current assets
total current assets	21,360,808	23,184,085	19,787,561	21,078,945	18,121,552	20,685,967	21,443,662	38,419,501	61,604,779	64,073,502	72,288,220	72,646,026	75,699,848	72,463,119	67,694,683
total assets	22,137,710	23,960,987	20,564,466	21,856,847	18,899,454	21,538,671	22,221,565	50,635,744	75,873,406	77,463,573	86,064,319	84,435,889	84,803,080	81,541,787	77,067,451
Bank overdraft
Bank loan
Trade Creditors	6,574,187	7,574,353	6,082,989	7,064,482	5,091,247	6,129,943	4,625,568	16,909,980	29,472,354	31,366,153	31,978,205	30,421,110	29,819,168	26,509,636	25,405,454
Group/Directors Accounts	297,096	304,528	308,673	2,296,180	3,391,672	8,653,706	14,450,036	24,157,260	24,707,034	24,746,310	33,557,616	34,232,198	34,268,411	35,102,568	33,044,458
other short term finances
hp & lease commitments
other current liabilities	2,047,229	1,849,814	2,636,767	2,193,848	2,124,078	1,626,881	535,555	2,952,446	3,624,047	6,192,599	5,899,584	7,372,836	8,468,034	9,140,894	9,238,097
total current liabilities	8,918,512	9,728,695	9,028,429	11,554,510	10,606,997	16,410,530	19,611,159	44,019,686	57,803,435	62,305,062	71,435,405	72,026,144	72,555,613	70,753,098	67,688,009
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions								86,050	120,066
total long term liabilities								4,423,050	2,528,066	2,020,500	1,247,500	2,312,350	2,635,000	2,577,880	1,836,880
total liabilities	8,918,512	9,728,695	9,028,429	11,554,510	10,606,997	16,410,530	19,611,159	48,442,736	60,331,501	64,325,562	72,682,905	74,338,494	75,190,613	73,330,978	69,524,889
net assets	13,219,198	14,232,292	11,536,037	10,302,337	8,292,457	5,128,141	2,610,406	2,193,008	15,541,905	13,138,011	13,381,414	10,097,395	9,612,467	8,210,809	7,542,562
total shareholders funds	13,219,198	14,232,292	11,536,037	10,302,337	8,292,457	5,128,141	2,610,406	2,193,008	15,541,905	13,138,011	13,381,414	10,097,395	9,612,467	8,210,809	7,542,562

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	1,730,568	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,388,306	264,088	4,376,186	4,788,022	4,824,561	6,296,527	4,870,802	4,673,887	4,361,906
Depreciation							419,896	2,131,085	1,165,798	1,126,000	1,019,172	735,286	815,669	931,856	868,255
Amortisation							40,933	32,094	7,406	7,406	7,406	7,408	7,406	7,406	7,406
Tax		753,512	-268,603	-470,286	-615,183	-506,175	-689,714	593,134	-901,766	-803,049	-713,239	-1,169,216	-1,253,118	-1,229,306	-498,978
Stock	-563,712	1,098,369	-881,160	2,514,506	-707,570	1,106,678	-3,635,601	7,231,610	-247,618	-455,387	16,571	-1,541,711	2,043,657	1,081,835	10,398,396
Debtors	-2,710,502	638,959	4,484,932	-1,092,486	1,003,689	-1,675,343	-11,309,614	21,439,769	-6,225,798	-9,450,546	-1,206,963	-669,476	1,722,367	-879,303	51,414,218
Creditors	-1,000,166	1,491,364	-981,493	1,973,235	-1,038,696	1,504,375	-12,284,412	16,909,980	-1,893,799	-612,052	1,557,095	601,942	3,309,532	1,104,182	25,405,454
Accruals and Deferred Income	197,415	-786,953	442,919	69,770	497,197	1,091,326	-2,416,891	2,952,446	-2,568,552	293,015	-1,473,252	-1,095,198	-672,860	-97,203	9,238,097
Deferred Taxes & Provisions							-86,050	86,050	120,066
Cash flow from operations	4,202,031	1,421,908	-2,908,761	2,619,722	2,268,425	5,847,510	1,317,283	-5,702,502	6,778,755	14,705,275	6,412,135	7,587,936	3,311,407	5,188,290	-22,430,474
Investing Activities
capital expenditure							9,503,172	-12,127,180	-1,562,431	-947,877	-3,012,814	-3,429,325	-847,639	-645,162	-9,270,023
Change in Investments		-3	-997		-74,802	74,801	-1,474,339	2,252,242	489,329	-200,499					978,406
cash flow from investments		3	997		74,802	-74,801	10,977,511	-14,379,422	-2,051,760	-747,378	-3,012,814	-3,429,325	-847,639	-645,162	-10,248,429
Financing Activities
Bank loans
Group/Directors Accounts	-7,432	-4,145	-1,987,507	-1,095,492	-5,262,034	-5,796,330	-9,707,224	24,157,260	-39,276	-8,811,306	-674,582	-36,213	-834,157	2,058,110	33,044,458
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue								14,199,943	15,087	-916,469	820,370	-925,846	-82,435	-804,636	4,530,807
interest	256,338	241,430	115	11,143	58,273	-165,409	-281,194	-673,965	-178,613	-313,056	-993,758	-1,216,537	866,409	28,302	-2,109,748
cash flow from financing	248,906	237,285	-1,987,392	-1,084,349	-5,203,761	-5,961,739	-9,988,418	37,683,238	-202,802	-10,040,831	-847,970	-2,178,596	-50,183	1,281,776	35,465,517
cash and cash equivalents
cash	1,450,937	1,659,196	-4,895,156	1,535,373	-2,860,534	-189,030	-2,030,624	9,748,122	4,004,693	1,691,215	832,586	-842,635	-529,295	4,565,904	5,882,069
overdraft
change in cash	1,450,937	1,659,196	-4,895,156	1,535,373	-2,860,534	-189,030	-2,030,624	9,748,122	4,004,693	1,691,215	832,586	-842,635	-529,295	4,565,904	5,882,069

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for sangers (northern ireland) limited. Get real-time insights into sangers (northern ireland) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for sangers (northern ireland) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in BT5 area or any other competitors across 12 key performance metrics.

SANGERS (NORTHERN IRELAND) LIMITED group structure

Sangers (Northern Ireland) Limited has 3 subsidiary companies.

Ultimate parent company

AURELIUS INVESTMENT LUX ONE SARL

#0143598

AAH PHARMACEUTICALS LIMITED

00123458

2 parents

SANGERS (NORTHERN IRELAND) LIMITED

NI018941

3 subsidiaries

BLACKSTAFF PHARMACEUTICALS LIMITED

03754932

PRIMA BRANDS LIMITED

NI010262

J. BRADBURY (SURGICAL) LIMITED

NI035736

SANGERS (NORTHERN IRELAND) LIMITED Shareholders

aah pharmaceuticals limited

100%

Sangers (Northern Ireland) Limited currently has 5 directors. The longest serving directors include Mr Peter Surgenor (Jan 2003) and Ms Wendy Hall (Jul 2022).

officer	country	age	start	end	role
Mr Peter Surgenor	Northern Ireland	67 years	Jan 2003	-	Director
Ms Wendy Hall	England	54 years	Jul 2022	-	Director
Mrs Wendy Hall	England	54 years	Jul 2022	-	Director
Mr David Bound	England	63 years	Dec 2022	-	Director
Mr Adrian Stubbings	England	52 years	Feb 2024	-	Director

P&L

March 2024

turnover

48.5m

-1%

operating profit

1.7m

+2%

gross margin

12%

+5.62%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

13.2m

-0.07%

total assets

22.1m

-0.08%

cash

4.4m

+0.49%

net assets

Total assets minus all liabilities

Similar Companies

strathclyde pharmaceuticals limited

donald wardle and son limited

n.g. limited

respond healthcare limited

chemilines group holdings limited

company number

NI018941

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

May 1985

ultimate parent company

AURELIUS INVESTMENT LUX ONE SARL

previous names

N/A

address

2 marshalls road, belfast, bt5 6sr, BT5 6SR

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to sangers (northern ireland) limited. Currently there are 1 open charges and 2 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SANGERS (NORTHERN IRELAND) LIMITED. This can take several minutes, an email will notify you when this has completed.

sangers (northern ireland) limited Company Information

sangers (northern ireland) limited Estimated Valuation

sangers (northern ireland) limited Estimated Valuation

sangers (northern ireland) limited Estimated Valuation

Sangers (northern Ireland) Limited Overview

Sangers (northern Ireland) Limited Health Check

SANGERS (NORTHERN IRELAND) LIMITED financials

sangers (northern ireland) limited Credit Report and Business Information

Sangers (northern Ireland) Limited Competitor Analysis

sangers (northern ireland) limited Ownership

sangers (northern ireland) limited directors

sangers (northern ireland) limited company details

sangers (northern ireland) limited Charges & Mortgages

sangers (northern ireland) limited Capital Raised & Share Issues BETA

sangers (northern ireland) limited Companies House Filings - See Documents